AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,795 | -43.2% | 75,683 | -38.7% | 0.00% | -100.0% |
| Q2 2023 | $203,787 | +1050.2% | 123,507 | +694.7% | 0.00% | – |
| Q1 2023 | $17,718 | -77.6% | 15,542 | -21.6% | 0.00% | – |
| Q2 2021 | $79,000 | -65.5% | 19,824 | -53.7% | 0.00% | -100.0% |
| Q4 2020 | $229,000 | -75.7% | 42,797 | -77.9% | 0.00% | -86.7% |
| Q2 2020 | $942,000 | +2516.7% | 193,856 | +1080.2% | 0.02% | +1400.0% |
| Q1 2020 | $36,000 | -67.0% | 16,425 | -11.9% | 0.00% | 0.0% |
| Q4 2019 | $109,000 | -16.2% | 18,650 | -54.3% | 0.00% | 0.0% |
| Q3 2019 | $130,000 | -18.8% | 40,777 | +6.8% | 0.00% | -50.0% |
| Q2 2019 | $160,000 | +44.1% | 38,190 | +138.7% | 0.00% | +100.0% |
| Q1 2019 | $111,000 | -41.0% | 16,000 | -46.4% | 0.00% | -50.0% |
| Q4 2018 | $188,000 | – | 29,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |